BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31297877)

  • 1. Neurexophilin and PC-esterase domain family member 4 (NXPE4) and prostate androgen-regulated mucin-like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer.
    Liu YR; Hu Y; Zeng Y; Li ZX; Zhang HB; Deng JL; Wang G
    J Cell Biochem; 2019 Oct; 120(10):18041-18052. PubMed ID: 31297877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer.
    Huang Z; Yang Q; Huang Z
    Med Sci Monit; 2018 Jul; 24():4625-4633. PubMed ID: 29973580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
    Zhang H; Dong S; Feng J
    J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.
    Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S
    Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent prognostic genes and mechanism investigation for colon cancer.
    Li C; Shen Z; Zhou Y; Yu W
    Biol Res; 2018 Apr; 51(1):10. PubMed ID: 29653552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
    Gao X; Yang J
    DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory genes are novel prognostic biomarkers for colorectal cancer.
    Jiang H; Dong L; Gong F; Gu Y; Zhang H; Fan D; Sun Z
    Int J Mol Med; 2018 Jul; 42(1):368-380. PubMed ID: 29693170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
    Yuan J; Xie A; Cao Q; Li X; Chen J
    Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal Cancer.
    Watanabe T; Shiozawa M; Kimura Y; Hiroshima Y; Hashimoto I; Komori K; Watanabe H; Kano K; Fujikawa H; Aoyama T; Numata M; Yamada T; Tamagawa H; Ogata T; Yukawa N; Morinaga S; Rino Y; Masuda M; Miyagi Y; Oshima T
    Anticancer Res; 2021 Apr; 41(4):2117-2122. PubMed ID: 33813422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
    Fan Q; Liu B
    J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer.
    Ma J; Zhang S; Hu Y; Li X; Yuan F; Sun D; Wang L; Zhang F; Chen G; Cui P
    Medicine (Baltimore); 2017 Oct; 96(42):e7011. PubMed ID: 29049167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
    Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
    Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of a common different gene expression signature in patients with colorectal cancer.
    Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
    Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and verification of key cancer genes associated with prognosis of colorectal cancer based on bioinformatics analysis.
    Qin Y; Chen L; Chen L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 46(10):1063-1070. PubMed ID: 34911835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.